B
BARRX Medical
GI Solutions focuses on the ongoing research and treatment of Barrett's esophagus for the treatment of patients diagnosed with the disease
About BARRX Medical
Founded in 2000 and based in Sunnyvale, California, BARRX Medical, Inc. carved a specific niche within the medical device sector by focusing on treatments for gastroenterological diseases. The company was steered by key figures including President and CEO Greg Barrett and Chief Medical Officer David S. Utley, M.D. Their leadership was pivotal in developing and commercializing a novel approach to managing Barrett's esophagus, a precancerous condition resulting from chronic gastroesophageal reflux disease (GERD).
The company's core business revolves around the HALO Radiofrequency Ablation (RFA) System. This platform provides a minimally invasive solution for gastroenterologists and surgeons to remove diseased esophageal tissue endoscopically. The technology is designed to deliver a controlled burst of radiofrequency energy to the targeted lining of the esophagus, ablating the precancerous cells without damaging the underlying healthy tissue. The goal is to allow the esophagus to heal and be replaced by a normal, healthy lining. The HALO system includes a radiofrequency generator and a portfolio of ablation catheters, such as the HALO360 and HALO90, which are designed to treat different sizes and shapes of affected areas within the esophagus.
BARRX Medical's business model centered on selling these specialized devices to hospitals and outpatient surgery centers where endoscopic procedures are performed. The company's value proposition rested on providing a less invasive alternative to surgical intervention for patients with Barrett's esophagus, thereby potentially preventing the progression to esophageal cancer. Following a series of successful funding rounds and the establishment of robust clinical evidence for its technology, BARRX Medical positioned itself as a significant player in its market. This culminated in its acquisition by Covidien, a global healthcare products company, in a deal announced in late 2011 and completed in early 2012 for approximately $325 million. The acquisition integrated BARRX's technology into Covidien's energy-based device portfolio. Subsequently, Covidien itself was acquired by Medtronic in a major transaction that closed in 2015, placing the BARRX RFA technology under the Medtronic umbrella.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Employees
- 17
- Open positions
- None listed
- Dealroom signal
- 25.3/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotechnology, Oncology, Gastroenterology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Nov 2011 | $325M | $325M | Covidien | — |
| SERIES D✓Equity / VC | Jul 2010 | $15M | $60M | Sutter Hill Ventures · Frazier Healthcare Partners · Greenspring Associates · Highland Capital Partners | — |
Growth signals
Latest recorded traffic for BARRX Medical is 140 monthly website visits, up 16.7% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
BARRX Medical in the Sunnyvale ecosystem
The BARRX Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later6 investors entered at this stage
- AVAlloy Ventures
Delphi Ventures
Sutter Hill Ventures
Frazier Healthcare Partners
Highland Capital Partners
Greenspring Associates
Other known investors1 additional known investor
Covidien
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about BARRX Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BARRX Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










